Cargando…
Targeting Mcl-1 Degradation by Bergenin Inhibits Tumorigenesis of Colorectal Cancer Cells
Myeloid leukemia 1 (Mcl-1) is frequently overexpressed in human malignancies and emerged as a promising drug target. In this study, we verified the inhibitory effect of bergenin on colorectal cancer cells both in vivo and in vitro. In an in vitro setting, bergenin significantly reduced the viability...
Autores principales: | Gan, Yu, Li, Xiaoying, Han, Shuangze, Zhou, Li, Li, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965350/ https://www.ncbi.nlm.nih.gov/pubmed/37259388 http://dx.doi.org/10.3390/ph16020241 |
Ejemplares similares
-
Stabilization of MCL-1 by E3 ligase TRAF4 confers radioresistance
por: Li, Ming, et al.
Publicado: (2022) -
Correction to: Stabilization of MCL-1 by E3 ligase TRAF4 confers radioresistance
por: Li, Ming, et al.
Publicado: (2023) -
The cGAS/STING Pathway: A Novel Target for Cancer Therapy
por: Gan, Yu, et al.
Publicado: (2022) -
Licochalcone A Promotes the Ubiquitination of c-Met to Abrogate Gefitinib Resistance
por: Han, Shuangze, et al.
Publicado: (2022) -
FBW7 mutations mediate resistance of colorectal cancer to targeted therapies by blocking Mcl-1 degradation
por: Tong, Jingshan, et al.
Publicado: (2016)